1830 Results

People

  1. Brennan
    Brennan
  2. Fong
    Fong
  3. Danishefsky
    Danishefsky
  4. Leibel
    Leibel
  5. Moore
    Moore
  6. Cordon-Cardo
    Cordon-Cardo
  7. Blumgart
    Blumgart
  8. Scheinberg
    Scheinberg
  9. Pandolfi Derinaldis
    Pandolfi Derinaldis
  10. Scher
    Scher

Groups

  1. Sloan Kettering Institute Faculty (434)
  2. Department of Medicine (425)
  3. GSK Faculty (356)
  4. Surgery (298)
  5. Molecular Pharmacology and Chemistry Program Faculty (249)
  6. Solid Tumor Oncology Division (210)
  7. Survivorship Research (173)
  8. Tow Center for Developmental Oncology (TCDO) (135)
  9. Center for Hematologic Malignancies (128)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (119)
  1. "2000"
Formats
  1. Journal Article (1261)
  2. Meeting Abstract (388)
  3. Book Section (140)
  4. Conference Paper (30)
  5. Book Whole (11)
Groups
  1. Sloan Kettering Institute Faculty (434)
  2. Department of Medicine (425)
  3. GSK Faculty (356)
  4. Surgery (298)
  5. Molecular Pharmacology and Chemistry Program Faculty (249)
  6. Solid Tumor Oncology Division (210)

More Groups

People
  1. Murray Brennan (43)
  2. Yuman Fong (38)
  3. Samuel Danishefsky (37)
  4. Steven Larson (35)
  5. Steven Leibel (35)
  6. Malcolm Moore (33)

More People

Years
  1. 2000 (1830)
Publications
  1. Blood (101)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (69)
  3. Clinical Cancer Research (40)
  4. Cancer (39)
  5. International Journal of Radiation Oncology, Biology, Physics (39)
  6. Journal of Biological Chemistry (36)

More Publications

Publishers
  1. Elsevier Inc. (192)
  2. American Association for Cancer Research (135)
  3. Lippincott Williams & Wilkins (130)
  4. American Society of Hematology (101)
  5. Wiley Blackwell (87)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (1830)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The antagonistic relationship between open brain and Sonic Hedgehog in patterning the mouse neural tube
    Meeting Abstract

    Eggenschwiler, J. T.; Anderson, K. V.
    Developmental Biology (2000)

    Fulltext@MSK | Save
  • A molecular basis for competence and for the specificity of Ras signaling in mesoderm development
    Meeting Abstract

    Halfon, M. S.; Carmena, A.; Baylies, M.; Michelson, A. M.
    Developmental Biology (2000)

    Fulltext@MSK | Save
  • The cloning of a novel candidate gene for the Amnionless mutation
    Meeting Abstract

    Kalantry, S.; Manning, S.; Tomihara-Newberger, C.; Haub, O.; Lee, H. G.; Manova, K.; Lacy, E.
    Developmental Biology (2000)

    Fulltext@MSK | Save
  • Comparison of serum and tissue HER-2/neu expression in breast and prostate cancers
    Meeting Abstract

    Neaman, I. E.; Contois, J. H.; Smith, C.; Schwartz, D.; Schwartz, M. K.; Yeung, K. K.; Allard, W. J.
    Clinical Chemistry (2000)

    Fulltext@MSK | Save
  • Ras and Notch signaling pathways interact to generate specific cell fates during Drosophila mesoderm differentiation
    Meeting Abstract

    Carmena, A.; Buff, E.; Jimenez, F.; Baylies, M.; Michelson, A.
    Developmental Biology (2000)

    Fulltext@MSK | Save
  • A phase I study of a novel antimicrotubule agent: T138067
    Meeting Abstract

    Budman, D. R.; Berg, W. B.; Spriggs, D. R.; Vongprachnach, P.; O'Mara, V.; Wright, M.; Walling, J.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Phase I and pharmacology study of the epothilone B analog BMS-247550 in patients with advanced cancer
    Meeting Abstract

    Spriggs, D.; Soignet, S.; Bienvenu, B.; Letrent, S.; Lebwohl, D.; Burris, H.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Lack of "PSA Gap" using the Bayer Immuno I Complexed PSA assay
    Meeting Abstract

    Cheli, C. D.; Neaman, I.; Goldblatt, J. L.; Cook, G. B.; Loughlin, K.; Schwartz, M. K.; Chan, D. W.; Yeung, K. K.; Allard, W. J.
    Clinical Chemistry (2000)

    Fulltext@MSK | Save
  • Age-specific serum levels of PSA, complexed PSA (cPSA) and percent cPSA in men without clinical evidence of prostate cancer, men with benign prostatic hypertrophy (BPH) and those with prostate cancer (CaP)
    Meeting Abstract

    Cheli, C. D.; Cook, G. B.; Neaman, I.; Goldblatt, J. L.; Hussain, M.; Loughlin, K.; Schwartz, M. K.; Yeung, K. K.; Allard, W. J.
    Clinical Chemistry (2000)

    Fulltext@MSK | Save
  • Phase I trial of a synthetic Lewis(Y) - KLH conjugate vaccine on ovarian cancer patients
    Meeting Abstract

    Sabbatini, P.; Kudryashov, V.; Ragupathi, G.; Danishefsky, S.; Livingston, P.; Bornmann, W.; Spassova, M.; Zatorski, A.; Spriggs, D.; Aghajanian, C.; more...
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save